sprite-preloader
Anzeige
Mehr »
Dienstag, 24.04.2018 Börsentäglich über 12.000 News von 574 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von PharmaTimes

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
15:12Probiodrug appoints Ulrich Dauer as CEO
12:42Redx appoints senior AstraZeneca executive as new CEO
12:42PureTech Health appoints Joep Muijrers as chief financial officer
12:12FDA advisors back Lilly/Incyte's rheumatoid arthritis drug
12:12MHRA bans valproate without pregnancy prevention programme
11:42EU reviewing MSD's Keytruda/chemo combo
11:12FDA rejects Pfizer's Herceptin biosimilar
11:12AstraZeneca lung cancer combo fails to hit targets
MoNeil Levinson joins Accretio as strategy director
MoMinisters write letter to Vertex over Orkambi debate
MoFresenius pulls out of $4.3bn Akorn merger
MoTakeda ups its offer for Shire
MoCHMP rejects AB Science's ALS drug
FrCommunications Team of the Year: Join our exclusive alumni of fellow Pharma winners!
FrClinical Researcher of the Year finalists to face toughest challenge yet
FrShire turns down Takeda's advances
FrFDA advisors back approval of GW's Epidiolex
FrUS widens use of AstraZeneca' Tagrisso in lung cancer
FrMerck sells consumer healthcare unit to P&G
FrMarketer of the Year announces exciting new category
DoFDA clears first therapy for inherited rickets
DoFinal NHS nod for Roche's RoActemra
DoGW's Epidiolex takes a leap toward US approval
DoMPs slate rate of progress on NHS cyber security
MiCR UK, AACR form international cancer alliance